Boston Scientific Medsurg — Depreciation increased by 6.9% to $31.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 3.1%, from $32.00M to $31.00M. Over 4 years (FY 2021 to FY 2025), Medsurg — Depreciation shows an upward trend with a 9.2% CAGR.
An increase often reflects higher capital investment in manufacturing capacity, while a decrease may suggest aging assets or reduced capital intensity.
The systematic allocation of the cost of tangible assets used specifically within the MedSurg segment over their useful...
Standard 'Segment Depreciation' reported by capital-intensive manufacturing firms.
bsx_segment_medsurg_depreciation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20.25M | $20.25M | $20.25M | $22.00M | $22.00M | $22.00M | $22.00M | $25.75M | $25.75M | $25.75M | $25.75M | $24.00M | $27.00M | $27.00M | $32.00M | $27.00M | $28.00M | $29.00M | $31.00M |
| QoQ Change | — | +0.0% | +0.0% | +8.6% | +0.0% | +0.0% | +0.0% | +17.0% | +0.0% | +0.0% | +0.0% | -6.8% | +12.5% | +0.0% | +18.5% | -15.6% | +3.7% | +3.6% | +6.9% |
| YoY Change | — | — | — | — | +8.6% | +8.6% | +8.6% | +17.0% | +17.0% | +17.0% | +17.0% | -6.8% | +4.9% | +4.9% | +24.3% | +12.5% | +3.7% | +7.4% | -3.1% |